| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/01/2007 | US20070028311 Therapeutic and diagnostic means for papillomas and other diseases involving ped/pea-15 |
| 02/01/2007 | US20070027634 Molecular hepatotoxicology modeling |
| 02/01/2007 | US20070027383 Patches, systems, and methods for non-invasive glucose measurement |
| 02/01/2007 | US20070027309 Nucleic acid and amino acid sequences relating to Candida albicans for diagnostics and therapeutics |
| 02/01/2007 | US20070027304 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070027164 Agents for treating neurodegenerative diseases |
| 02/01/2007 | US20070027103 Methods and compositions for silencing genes without inducing toxicity |
| 02/01/2007 | US20070027101 Treating ocular neovascular disease using anti-VEGF therapy in combination with a second therapy that inhibits the development of ocular neovascularization or destroys abnormal blood vessels in the eye, such as photodynamic therapy |
| 02/01/2007 | US20070027095 Using nicotinamide riboside-related prodrug for treatment and prevention of cell proliferative disorders |
| 02/01/2007 | US20070027089 Inhibitors of amyloid precursor protein processing |
| 02/01/2007 | US20070026503 Human Leukocyte Antigen-A*02-restricted cellular epitopes within the VP1 polypeptide of a human polyomavirus; vaccines |
| 02/01/2007 | US20070026499 nucleotide or DNA constructs comprising expression cassettes comprising promoters operably linked to transgene open reading frames, used in protein production, diagnostics, transgenic plants and animals and the therapeutic field |
| 02/01/2007 | US20070026498 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/01/2007 | US20070026494 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026487 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/01/2007 | US20070026483 Kit for their detection in samples; Ponceau S dye and the cationic carbocyanine dye 1-Ethyl-2-[3-(1-ethylnaphtho[1,2-d]thiazolin-2-ylidene)-2-methylpropenyl]naphtho[1,2-d]thiazolium bromide together form light stable complex detectable by light microscopes |
| 02/01/2007 | US20070026482 which has glucosidase activity; substrate comprises 4-methylumbelliferyl- alpha -D-glucoside; medium based on Tryptone Bile agar |
| 02/01/2007 | US20070026481 Toxic mold screening kit & method for the colorimetric determination of the presence or absence of the toxic mold stachybotrys chartarum and other toxic environmental molds |
| 02/01/2007 | US20070026480 Method and composition to evaluate cytochrome P450 2D6 isoenzyme activity using a breath test |
| 02/01/2007 | US20070026479 Liquid protein markers for native gel electrophoresis |
| 02/01/2007 | US20070026478 Hemiasterlin affinity probes and their uses |
| 02/01/2007 | US20070026477 Whole cell assay involving cathepsin s |
| 02/01/2007 | US20070026476 Compounds, methods, complexes, apparatuses and uses relating to stabile forms of nad/nadh |
| 02/01/2007 | US20070026470 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026454 Human secreted proteins |
| 02/01/2007 | US20070026453 Kits for classification of patients who are unlikely to be cured by conventional therapy and in whom investigational approaches would be justified in an effort to improve their outcome |
| 02/01/2007 | US20070026452 Aspartoacylase gene, protein, and methods of screening for mutations associated with canavan disease |
| 02/01/2007 | US20070026451 Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules |
| 02/01/2007 | US20070026450 Methods for the treatment of carcinoma |
| 02/01/2007 | US20070026449 Novel human sodium-dependent phosphate cotransporter |
| 02/01/2007 | US20070026448 vectors, host cells, and recombinant and synthetic methods for producing said polypeptides; polypeptide has N-formyl peptide receptor activity |
| 02/01/2007 | US20070026447 Nucleotides |
| 02/01/2007 | US20070026446 Enhanced genome copy number, and capacity for expression and/or secretion of proteins and secondary metabolites |
| 02/01/2007 | US20070026445 Novel steroid-activated nuclear receptors and uses therefor |
| 02/01/2007 | US20070026444 Thermal cycling in polymerase chain reactions by thermodynamic methods |
| 02/01/2007 | US20070026443 Diagnosis of uniparental disomy with the aid of single nucleotide polymorphisms |
| 02/01/2007 | US20070026442 Analytical method and device |
| 02/01/2007 | US20070026441 Methods for reducing viral load in HIV-1-infected patients |
| 02/01/2007 | US20070026440 Identification, diagnosis, and treatment of neuropathologies, neurotoxicities, tumors, and brain and spinal cord injuries using electrodes with microvoltammetry |
| 02/01/2007 | US20070026439 Fluid processing device and method |
| 02/01/2007 | US20070026438 Methods of producing and sequencing modified polynucleotides |
| 02/01/2007 | US20070026437 Novel BMP products |
| 02/01/2007 | US20070026436 Glucose transport-related genes, polypeptides, and methods of use thereof |
| 02/01/2007 | US20070026435 Hydroxysilane functionalized magnetic particles and nucleic acid separation method |
| 02/01/2007 | US20070026434 Mobility-Modified Nucleobase Polymers and Methods of Using Same |
| 02/01/2007 | US20070026433 Epitope testing using soluble HLA |
| 02/01/2007 | US20070026432 Separation and purification of nucleic acid from paraffin-containing samples |
| 02/01/2007 | US20070026431 Modulation of MAPK-mediated phosphorylation and/or FBXW8-mediated ubiquitinylation of cyclin D1 in modulation of cellular proliferation |
| 02/01/2007 | US20070026430 Proximity probing of target proteins comprising restriction and/or extension |
| 02/01/2007 | US20070026429 Binary probe and clamp composition and methods for target hybridization detection |
| 02/01/2007 | US20070026428 Combinatorial expression of split caspase molecules |
| 02/01/2007 | US20070026427 detection of early cancers and premalignant neoplasms and invasive or advanced cancers, and for the monitoring of patients during treatment therapy and for post-operative monitoring, and to develop appropriate patient-specific treatment strategies |
| 02/01/2007 | US20070026426 System for genetic surveillance and analysis |
| 02/01/2007 | US20070026425 Hepatitis C virus Non-structural NS3/4A fusion gene |
| 02/01/2007 | US20070026424 Gene profiles correlating with histology and prognosis |
| 02/01/2007 | US20070026423 Method and test kit for the detection of target nucleic acids |
| 02/01/2007 | US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof |
| 02/01/2007 | US20070026421 Method and apparatus for generating thermal melting curves in a microfluidic device |
| 02/01/2007 | US20070026420 Novel EGIII-like enzymes, DNA encoding such enzymes and methods for producing such enzymes |
| 02/01/2007 | US20070026419 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| 02/01/2007 | US20070026418 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| 02/01/2007 | US20070026417 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| 02/01/2007 | US20070026416 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| 02/01/2007 | US20070026415 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| 02/01/2007 | US20070026414 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| 02/01/2007 | US20070026413 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| 02/01/2007 | US20070026412 Multiplex PCR for the detection of AmpC beta-lactamase genes |
| 02/01/2007 | US20070026411 digesting the tissue specimen, purifying RNA from specimen, treating the purified RNA fraction with cyclic phosphodiesterase, phosphatase, or kinase to provide a sample with dephosphorylated RNA which is contacted with enzyme having RNA ligation activity in the presence of a labeled substrate |
| 02/01/2007 | US20070026410 Nucleoside cyanine dye derivatives for RNA labeling and nucleic acid detection and methods for using same |
| 02/01/2007 | US20070026409 Nucleic acid and amino acid sequences involved in pain |
| 02/01/2007 | US20070026408 Materials and methods for analysis of atp-binding cassette transporter gene expression |
| 02/01/2007 | US20070026407 Novel fine fluorescent particle |
| 02/01/2007 | US20070026406 Apparatus and method for classifying multi-dimensional biological data |
| 02/01/2007 | US20070026405 Materials and methods for colorectal cancer screening, diagnosis and therapy |
| 02/01/2007 | US20070026404 Production characteristics of cattle |
| 02/01/2007 | US20070026403 Method and systems for identifying micro-rna targets and synthesizing novel micro-rnas and uses of the same |
| 02/01/2007 | US20070026402 Genetic marker of response to atypical antipsychotics and antidepressants methods for use thereof |
| 02/01/2007 | US20070026401 Method and apparatus for spore disruption and/or detection |
| 02/01/2007 | US20070026400 Multi-hybridization set for dna microarray related assay |
| 02/01/2007 | US20070026399 Diagnosis of gynecological neoplasms by detecting the levels of oviduct-specific glycoprotein |
| 02/01/2007 | US20070026398 Protein tyrosine phosphatase-prl-1 a a marker and therapeutic target for pancreatic cancer |
| 02/01/2007 | US20070026397 Method for producing second-generation library |
| 02/01/2007 | US20070026396 Peptides directed against antibodies, which cause cold-intolerance, and the use thereof |
| 02/01/2007 | US20070026395 Human cancer-relating genes, the products encoded thereby and applications thereof |
| 02/01/2007 | US20070026394 Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies |
| 02/01/2007 | US20070026393 Detection of variations in the dna methylation profile |
| 02/01/2007 | US20070026392 permit the assessment of agents without administration to subjects; using the artificial immune system of the invention for evaluating the potential reaction of a diseased animal to an agent |
| 02/01/2007 | US20070026391 Methods and compositions for identifying chemical or biological agents using multiplexed labeling and colocalization detection |
| 02/01/2007 | US20070026390 Development of diagnostic kit against the recombinant coat protein of prunus necrotic ringspot virus |
| 02/01/2007 | US20070026389 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 02/01/2007 | US20070026388 Analyte detection using carbon nanotubes |
| 02/01/2007 | US20070026387 Diagnosing systemic lupus erythematosus (SLE); lymphocyte |
| 02/01/2007 | US20070026386 Method for the detection of newly acquired hiv infection |
| 02/01/2007 | US20070026385 Screening agents that modify association of Gs alpha with adenylyl cyclase or components of the plasma membrane or cytoskeleton; fluorescence resonance energy transfer |
| 02/01/2007 | US20070026384 Detection of transmembrane potentials by optical methods |
| 02/01/2007 | US20070026383 Methods and compositions for extracting membrane proteins |
| 02/01/2007 | US20070026382 Label-free, highly parallel, qualitative and quantitative detection of specific cell populations in a sample and for assessing cell functional status, cell-cell interactions and cellular responses to drugs, environmental toxins, bacteria, viruses and other factors that may affect cell function |
| 02/01/2007 | US20070026381 Devices and methods for enrichment and alteration of cells and other particles |
| 02/01/2007 | US20070026380 System for water removal and solvent evaporation |
| 02/01/2007 | US20070026106 In situ production of an emulsifier in an egg, egg-based product or a dairy product from the lipid acyltransferase without a substantial increase in the free fatty acid content; anticholesterol agents |